News

Medpage Today on MSN12h
Nasal Powder for Acute Migraine Gets FDA Nod
The FDA approved dihydroergotamine (DHE) nasal powder (Atzumi) 5.2 mg to treat acute migraine with or without aura in adults, ...
Healio11h
FDA fast tracks urcosimod for neuropathic corneal pain
The FDA granted fast track designation to urcosimod to treat neuropathic corneal pain, according to a press release from Okyo Pharma. Urcosimod, formerly called OK-101, is a “lipid conjugated chemerin ...